Actively Recruiting
China Gender-affirming Hormone Therapy Study
Led by Peking University Third Hospital · Updated on 2024-11-07
240
Participants Needed
1
Research Sites
350 weeks
Total Duration
On this page
Sponsors
P
Peking University Third Hospital
Lead Sponsor
T
Tsinghua University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hormonal treatment in Chinese transgender population. CGAHT is designed to describe the social and mental condition of transgender people who are seeking for formal GAHT, and to investigate the physical and psychological effects of GAHT on this population in China.
CONDITIONS
Official Title
China Gender-affirming Hormone Therapy Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Transgender men and women
- Meet criteria of Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) for gender dysphoria
- Aged between 18 to 40 years
- Desire to start gender-affirming hormone therapy (GAHT)
- No previous history of gender-affirming interventions
- Able to give full informed consent
- Right-handed (dextromanual)
You will not qualify if you...
- Disorders of sex development
- Desire fertility but have not undergone fertility preservation
- Contraindications to gender-affirming hormone therapy
- Uncontrolled comorbid diseases
- Alcohol or drug abuse
- Hormonal or chromosomal disorders
- History of gender-affirming surgery
- Current psychiatric disorders
- History of brain trauma or neurological diseases
- Use of psychotropic medications within the last two weeks
- Claustrophobia
- Presence of implanted metal devices or pacemakers
- Heavy metal tattoos or eyebrow tattooing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
Y
Ye Liu, PhD., M.D.
CONTACT
T
Tianpei Hong, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here